An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

Novartis researchers are using data to accelerate drug development.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.

Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.

Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.

The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.